FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2172043742> ?p ?o ?g. }

• W2172043742 endingPage "1716" @default.
• W2172043742 startingPage "1705" @default.
• W2172043742 abstract "Abstract Purpose: Neuroblastoma (NB) is a neural crest-derived tumor that commonly occurs in childhood. β-1,4-Galactosyltransferase III (B4GALT3) is highly expressed in human fetal brain and is responsible for the generation of poly-N-acetyllactosamine, which plays a critical role in tumor progression. We therefore investigated the expression and role of B4GALT3 in NB. Experimental Design: We examined B4GALT3 expression in tumor specimens from 101 NB patients by immunohistochemistry and analyzed the correlation between B4GALT3 expression and clinicopathologic factors or survival. The functional role of B4GALT3 expression was investigated by overexpression or knockdown of B4GALT3 in NB cells for in vitro and in vivo studies. Results: We found that B4GALT3 expression correlated with advanced clinical stages (P = 0.040), unfavorable Shimada histology (P &lt; 0.001), and lower survival rate (P &lt; 0.001). Multivariate analysis showed that B4GALT3 expression is an independent prognostic factor for poor survival of NB patients. B4GALT3 overexpression increased migration, invasion, and tumor growth of NB cells, whereas B4GALT3 knockdown suppressed the malignant phenotypes of NB cells. Mechanistic investigation showed that B4GALT3-enhanced migration and invasion were significantly suppressed by β1-integrin blocking antibody. Furthermore, B4GALT3 overexpression increased lactosamine glycans on β1-integrin, increased expression of mature β1-integrin via delayed degradation, and enhanced phosphorylation of focal adhesion kinase. Conversely, these properties were decreased by knockdown of B4GALT3 in NB cells. Conclusions: Our findings suggest that B4GALT3 predicts an unfavorable prognosis for NB and may regulate invasive phenotypes through modulating glycosylation, degradation, and signaling of β1-integrin in NB cells. Clin Cancer Res; 19(7); 1705–16. ©2013 AACR." @default.
• W2172043742 created "2016-06-24" @default.
• W2172043742 creator A5006261464 @default.
• W2172043742 creator A5011607725 @default.
• W2172043742 creator A5016530655 @default.
• W2172043742 creator A5016980011 @default.
• W2172043742 creator A5017671441 @default.
• W2172043742 creator A5028118105 @default.
• W2172043742 creator A5028489918 @default.
• W2172043742 creator A5028852353 @default.
• W2172043742 creator A5031279164 @default.
• W2172043742 creator A5041418118 @default.
• W2172043742 creator A5041457441 @default.
• W2172043742 creator A5052359237 @default.
• W2172043742 creator A5057937159 @default.
• W2172043742 creator A5059600821 @default.
• W2172043742 creator A5065572900 @default.
• W2172043742 creator A5073677542 @default.
• W2172043742 creator A5077809487 @default.
• W2172043742 creator A5078054883 @default.
• W2172043742 creator A5086609279 @default.
• W2172043742 creator A5088498135 @default.
• W2172043742 date "2013-04-01" @default.
• W2172043742 modified "2023-10-18" @default.
• W2172043742 title "β-1,4-Galactosyltransferase III Enhances Invasive Phenotypes Via β1-Integrin and Predicts Poor Prognosis in Neuroblastoma" @default.
• W2172043742 cites W1582703272 @default.
• W2172043742 cites W1973186568 @default.
• W2172043742 cites W1975230522 @default.
• W2172043742 cites W1975317988 @default.
• W2172043742 cites W1981086877 @default.
• W2172043742 cites W1994260229 @default.
• W2172043742 cites W1995878243 @default.
• W2172043742 cites W2001475156 @default.
• W2172043742 cites W2003761224 @default.
• W2172043742 cites W2008545486 @default.
• W2172043742 cites W2034473543 @default.
• W2172043742 cites W2037828403 @default.
• W2172043742 cites W2037876225 @default.
• W2172043742 cites W2061781906 @default.
• W2172043742 cites W2062221655 @default.
• W2172043742 cites W2067606868 @default.
• W2172043742 cites W2068365812 @default.
• W2172043742 cites W2076424203 @default.
• W2172043742 cites W2080380130 @default.
• W2172043742 cites W2081042973 @default.
• W2172043742 cites W2091270752 @default.
• W2172043742 cites W2099370186 @default.
• W2172043742 cites W21547724 @default.
• W2172043742 cites W2156674768 @default.
• W2172043742 cites W2164182106 @default.
• W2172043742 cites W2164838392 @default.
• W2172043742 cites W2183079276 @default.
• W2172043742 cites W4211031423 @default.
• W2172043742 cites W4237937779 @default.
• W2172043742 cites W4322696075 @default.
• W2172043742 doi "https://doi.org/10.1158/1078-0432.ccr-12-2367" @default.
• W2172043742 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/23444218" @default.
• W2172043742 hasPublicationYear "2013" @default.
• W2172043742 type Work @default.
• W2172043742 sameAs 2172043742 @default.
• W2172043742 citedByCount "41" @default.
• W2172043742 countsByYear W21720437422014 @default.
• W2172043742 countsByYear W21720437422015 @default.
• W2172043742 countsByYear W21720437422016 @default.
• W2172043742 countsByYear W21720437422017 @default.
• W2172043742 countsByYear W21720437422018 @default.
• W2172043742 countsByYear W21720437422019 @default.
• W2172043742 countsByYear W21720437422020 @default.
• W2172043742 countsByYear W21720437422021 @default.
• W2172043742 countsByYear W21720437422022 @default.
• W2172043742 countsByYear W21720437422023 @default.
• W2172043742 crossrefType "journal-article" @default.
• W2172043742 hasAuthorship W2172043742A5006261464 @default.
• W2172043742 hasAuthorship W2172043742A5011607725 @default.
• W2172043742 hasAuthorship W2172043742A5016530655 @default.
• W2172043742 hasAuthorship W2172043742A5016980011 @default.
• W2172043742 hasAuthorship W2172043742A5017671441 @default.
• W2172043742 hasAuthorship W2172043742A5028118105 @default.
• W2172043742 hasAuthorship W2172043742A5028489918 @default.
• W2172043742 hasAuthorship W2172043742A5028852353 @default.
• W2172043742 hasAuthorship W2172043742A5031279164 @default.
• W2172043742 hasAuthorship W2172043742A5041418118 @default.
• W2172043742 hasAuthorship W2172043742A5041457441 @default.
• W2172043742 hasAuthorship W2172043742A5052359237 @default.
• W2172043742 hasAuthorship W2172043742A5057937159 @default.
• W2172043742 hasAuthorship W2172043742A5059600821 @default.
• W2172043742 hasAuthorship W2172043742A5065572900 @default.
• W2172043742 hasAuthorship W2172043742A5073677542 @default.
• W2172043742 hasAuthorship W2172043742A5077809487 @default.
• W2172043742 hasAuthorship W2172043742A5078054883 @default.
• W2172043742 hasAuthorship W2172043742A5086609279 @default.
• W2172043742 hasAuthorship W2172043742A5088498135 @default.
• W2172043742 hasBestOaLocation W21720437421 @default.
• W2172043742 hasConcept C104317684 @default.
• W2172043742 hasConcept C121608353 @default.
• W2172043742 hasConcept C127716648 @default.
• W2172043742 hasConcept C1491633281 @default.
• W2172043742 hasConcept C173396325 @default.

• next